FIBROBLAST-MEDIATED ACCELERATION OF HUMAN EPITHELIAL TUMOR-GROWTH INVIVO

被引:366
|
作者
CAMPS, JL
CHANG, SM
HSU, TC
FREEMAN, MR
HONG, SJ
ZHAU, HE
VONESCHENBACH, AC
CHUNG, LWK
机构
[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT UROL,UROL RES LAB,1515 HOLCOMBE BLVD,HOUSTON,TX 77030
[2] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT CELL BIOL,UROL RES LAB,HOUSTON,TX 77030
关键词
Prostate cancer; Stromal-epithelial interaction;
D O I
10.1073/pnas.87.1.75
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Transformed fibroblasts coinoculated with epithelial cells accelerated the growth and shortened the latency period of human epithelial tumors in athymic mice. Addition of NbF-1 fibroblasts caused epithelial tumors to grow from five marginally tumorigenic or "nontumorigenic" (nontumor-forming) human tumor cell lines or strains: PC-3 (prostate), WH (bladder), MDA-436 (breast), and cells derived from the ascites fluids of patients with metastatic renal pelvic or prostate cancers. Evidence for the human and epithelial nature of these experimental tumors was provided by histologic, immunohistochemical, Southern and dot-blot hybridization, and cytogenetic analyses. Transformed fibroblasts induced predominantly carcinosarcomas, whereas nontumorigenic fibroblasts (NTH 3T3) and lethally irradiated transformed fibroblasts induced exclusively carcinomas. The fibroblast-epithelial interaction appears to occur bidirectionally and does not result from cell fusion. Because coculture experiments in vitro did not demonstrate an increased cell proliferation, it appears that undefined host factors can influence tumor growth. This tumor model may be useful in drug-screening programs and in mechanistic studies of factors regulating human tumor growth and progression.
引用
收藏
页码:75 / 79
页数:5
相关论文
共 50 条
  • [11] THE INVIVO EFFECT OF PROTEIN-A ON TUMOR-GROWTH
    DIMA, S
    MORARU, I
    NEOPLASMA, 1986, 33 (06) : 679 - 684
  • [12] STUDIES ON THE ROLE OF BASIC FIBROBLAST GROWTH-FACTOR INVIVO - INABILITY OF NEUTRALIZING ANTIBODIES TO BLOCK TUMOR-GROWTH
    DENNIS, PA
    RIFKIN, DB
    JOURNAL OF CELLULAR PHYSIOLOGY, 1990, 144 (01) : 84 - 98
  • [13] INVIVO TUMOR-GROWTH INHIBITION BY CYCLIC NUCLEOTIDES
    CLAIR, T
    CHOCHUNG, YS
    FEDERATION PROCEEDINGS, 1974, 33 (05) : 1392 - 1392
  • [14] Epithelial cells promote fibroblast-mediated contraction of collagen gels by secreting bFGF
    Sharma, Maryada
    Lei, Hetian
    Pennock, Steven
    Kazlauskas, Andrius
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [15] TUMOR-GROWTH INVIVO SELECTS FOR RESISTANCE TO TUMOR NECROSIS FACTOR
    LATTIME, EC
    STUTMAN, O
    JOURNAL OF IMMUNOLOGY, 1989, 143 (12): : 4317 - 4323
  • [16] PROLACTIN PROMOTES PLASMACYTOMA TUMOR-GROWTH INVIVO AND INVITRO
    BERNTON, E
    GRZANNA, R
    FRONDOZA, C
    HOLADAY, J
    FEDERATION PROCEEDINGS, 1985, 44 (04) : 975 - 975
  • [17] Insulin-like growth factor 2 drives fibroblast-mediated tumor immunoevasion and confers resistance to immunotherapy
    Song, Daqiang
    Wu, Yushen
    Li, Jie
    Liu, Jiazhou
    Yi, Ziying
    Wang, Xiaoyu
    Sun, Jiazheng
    Li, Liuying
    Wu, Qianxue
    Chen, Yuru
    Fang, Huiying
    Luan, Tiankuo
    Du, Huimin
    Huang, Jing
    Peng, Weiyan
    Wei, Yuxian
    Li, Fan
    Li, Qin
    Zhang, Li
    Zhu, Yong
    Wan, Jingyuan
    Ren, Guosheng
    Li, Hongzhong
    JOURNAL OF CLINICAL INVESTIGATION, 2024, 134 (22):
  • [18] EFFECT OF FIBROBLAST INTERFERON ON COLONY TUMOR-GROWTH OF MISCELLANEOUS SOLID HUMAN-TUMORS
    SCHLAG, P
    WOLFRUM, J
    SCHREML, W
    HERFARTH, C
    KLINISCHE WOCHENSCHRIFT, 1982, 60 (23): : 1455 - 1459
  • [19] CORRELATION OF INVITRO METHODS FOR ASSESSMENT OF CELL-MEDIATED IMMUNITY (CMI) WITH INVIVO TUMOR-GROWTH
    FALK, RE
    MACGREGOR, AB
    NOSSAL, N
    FALK, JA
    CLINICAL RESEARCH, 1975, 23 (05): : A629 - A629
  • [20] ENHANCED TUMOR-GROWTH INVIVO BY A FACTOR IN HUMAN-PLATELETS AND RAT-LIVER
    WITKOSKI, E
    KEPNER, N
    LEITZEL, K
    ROGERS, C
    JEFFERSON, LS
    LIPTON, A
    CANCER RESEARCH, 1982, 42 (06) : 2350 - 2352